| 1 |
Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al. · Value in Health
Open access |
2016 |
755 |
| 2 |
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
Kevin Marsh, Maarten J. IJzerman, Praveen Thokala et al. · Value in Health
Open access |
Mar 2016 |
486 |
| 3 |
A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder
Tamás Ágh, Gábor László Kovács, Dylan Supina et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
ReviewOpen access |
4 Mar 2016 |
396 |
| 4 |
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review
Erik E. L. Jansen et al. · European Journal of Cancer
ReviewOpen access |
21 Jan 2020 |
272 |
| 5 |
Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review
Tamás Ágh, Gábor László Kovács, Manjiri D. Pawaskar et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
ReviewOpen access |
8 Jan 2015 |
162 |
| 6 |
The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis
Zoltán Vokó, János György Pitter · GeroScience
Open access |
11 Jun 2020 |
159 |
| 7 |
Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries
Bertalan Németh, Anett Molnár, Sándor Bozóki et al. · Journal of Comparative Effectiveness Research
Open access |
15 Feb 2019 |
148 |
| 8 |
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group
Sandra Nestler-Parr, Daria A. Korchagina, Mondher Toumi et al. · Value in Health
Open access |
11 Apr 2018 |
143 |
| 9 |
Policy objective of generic medicines from the investment perspective: The case of clopidogrel
Péter Elek, András Harsányi, Tamás Zelei et al. · Health Policy
|
7 Mar 2017 |
136 |
| 10 |
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
Ahmad Nader Fasseeh, Baher Elezbawy, Nada Korra et al. · Dermatology and Therapy
ReviewOpen access |
5 Oct 2022 |
135 |
| 11 |
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
Zoltán Vokó, Zoltán Kiss, György Surján et al. · Clinical Microbiology and Infection
Open access |
24 Nov 2021 |
133 |
| 12 |
Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group
Priti P. Pednekar, Tamás Ágh, Maria Malmenäs et al. · Value in Health
ReviewOpen access |
25 Oct 2018 |
128 |
| 13 |
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries
Tomasz Bochenek et al. · Frontiers in Pharmacology
Open access |
18 Jan 2018 |
115 |
| 14 |
Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus
William David Strain, Xavier Cos, Michael Hirst et al. · Diabetes Research and Clinical Practice
Open access |
27 May 2014 |
114 |
| 15 |
The Burden of Obesity in Egypt
Mohamed Aboulghate, Aliaa Aly El-Aghoury, Ibrahim Elebrashy et al. · Frontiers in Public Health
Open access |
27 Aug 2021 |
89 |
| 16 |
Drivers of successful implementation of integrated care for multi-morbidity: Mechanisms identified in 17 case studies from 8 European countries
Willemijn Looman, Verena Struckmann, Julia Köppen et al. · Social Science & Medicine
Open access |
5 Feb 2021 |
89 |
| 17 |
Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST)
Jennifer Priaulx, Harry J. de Koning, Inge M.C.M. de Kok et al. · Health Policy
Open access |
27 Aug 2018 |
85 |
| 18 |
Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs
Erik Baltaxe, Thomas Czypionka, Markus Kraus et al. · Journal of Medical Internet Research
Open access |
26 Sep 2019 |
81 |
| 19 |
Epidemiology of Sanfilippo syndrome: results of a systematic literature review
Tamás Zelei, Kata Csetneki, Zoltán Vokó et al. · Orphanet Journal of Rare Diseases
ReviewOpen access |
10 Apr 2018 |
81 |
| 20 |
Relationship Between Medication Adherence and Health-Related Quality of Life in Subjects With COPD: A Systematic Review
Tamás Ágh, Péterné Dömötör, Zoltán Bártfai et al. · Respiratory Care
ReviewOpen access |
2 Sep 2014 |
81 |
| 21 |
Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer
András Inotai, Tamás Ágh, R.F. van Maris et al. · Cancer Treatment Reviews
ReviewOpen access |
31 Jul 2021 |
79 |
| 22 |
HTA Implementation Roadmap in Central and Eastern European Countries
Zoltán Kaló, Adrian Gheorghe, Mirjana Huić et al. · Health Economics
Open access |
14 Jan 2016 |
77 |
| 23 |
Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines
Bogdan Grigore, Oriana Ciani, Florian Dams et al. · PharmacoEconomics
Open access |
22 Jun 2020 |
74 |
| 24 |
Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status
Ahmad Nader Fasseeh, Rita Karam, Mouna Jameleddine et al. · Frontiers in Pharmacology
Open access |
21 Feb 2020 |
73 |
| 25 |
Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency
Tímea Almási, Lin T. Guey, Christine Lukacs et al. · Orphanet Journal of Rare Diseases
ReviewOpen access |
25 Apr 2019 |
72 |
| 26 |
Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA)
Maureen Rutten‐van Mölken, Fenna Leijten, Maaike Jennifer Hoedemakers et al. · BMC Health Services Research
Open access |
24 Jul 2018 |
71 |
| 27 |
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
Tamás Zelei, Mária Judit Molnár, Márta Szegedi et al. · Orphanet Journal of Rare Diseases
ReviewOpen access |
4 Jun 2016 |
68 |
| 28 |
Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)
Jamie Elvidge et al. · Value in Health
Open access |
23 May 2024 |
67 |
| 29 |
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
Rositsa Koleva‐Kolarova, James P. Buchanan, Heleen Vellekoop et al. · Applied Health Economics and Health Policy
ReviewOpen access |
3 Apr 2022 |
66 |
| 30 |
Human health risk–benefit assessment of fish and other seafood: a scoping review
Sofie Theresa Thomsen, Ricardo Assunção, Cláudia M. Afonso et al. · Critical Reviews in Food Science and Nutrition
Open access |
6 May 2021 |
64 |
| 31 |
The European challenges of funding orphan medicinal products
Márta Szegedi, Tamás Zelei, Francis Arickx et al. · Orphanet Journal of Rare Diseases
Open access |
24 Oct 2018 |
64 |
| 32 |
Healthcare financing in Egypt: a systematic literature review.
Ahmad Nader Fasseeh, Baher Elezbawy, Wessam Adly et al. · Journal of the Egyptian Public Health Association
ReviewOpen access |
7 Jan 2022 |
61 |
| 33 |
Direct healthcare cost of schizophrenia – European overview
Gábor László Kovács, Tímea Almási, A. Millier et al. · European Psychiatry
Open access |
2018 |
58 |
| 34 |
Need for Multicriteria Evaluation of Generic Drug Policies
Zoltán Kaló, Anke‐Peggy Holtorf, Rafael Alfonso‐Cristancho et al. · Value in Health
Open access |
11 Feb 2015 |
56 |
| 35 |
The impact of the war on maintenance of long-term therapies in Ukraine
Nataliia Khanyk, Bohdan P. Hromovyk, Оksana Levytska et al. · Frontiers in Pharmacology
Open access |
24 Nov 2022 |
55 |
| 36 |
European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement
Job F. M. van Boven, Ioanna Tsiligianni, Ines Potočnjak et al. · Frontiers in Pharmacology
Open access |
11 Oct 2021 |
54 |
| 37 |
Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development
József Bodrogi, Zoltán Kaló · British Journal of Pharmacology
Open access |
2 Feb 2010 |
53 |
| 38 |
Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
Konstantin Tachkov, Antal Tamás Zemplenyi, Maria Kamusheva et al. · Frontiers in Public Health
Open access |
14 Jul 2022 |
52 |
| 39 |
Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Assessment Agencies
Oriana Ciani, Bogdan Grigore, Hedwig M. Blommestein et al. · Medical Decision Making
Open access |
10 Mar 2021 |
51 |
| 40 |
Is there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars
András Inotai, Christiaan P.J Prins, Marcell Csanádi et al. · Expert Opinion on Biological Therapy
Review |
26 Jun 2017 |
50 |
| 41 |
Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary
Zoltán Kaló, József Bodrogi, I Boncz et al. · Value in Health Regional Issues
Open access |
25 Jul 2013 |
50 |
| 42 |
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis
Heleen Vellekoop, Matthijs Versteegh, Simone A. Huygens et al. · Value in Health
ReviewOpen access |
2 Mar 2022 |
49 |
| 43 |
External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage
Anke‐Peggy Holtorf, Fotini Gialama, Kalman Emry Wijaya et al. · Value in Health Regional Issues
Open access |
12 Aug 2019 |
49 |
| 44 |
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
Piotr Ozierański, Marcell Csanádi, Emily Rickard et al. · JAMA Network Open
Open access |
21 Jun 2019 |
49 |
| 45 |
Differential pricing of new pharmaceuticals in lower income European countries
Zoltán Kaló, Lieven Annemans, Louis P. Garrison · Expert Review of Pharmacoeconomics & Outcomes Research
|
13 Nov 2013 |
49 |
| 46 |
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
Zoltán Kiss, István Wittmann, Lőrinc Polivka et al. · Frontiers in Immunology
Open access |
23 Jun 2022 |
48 |
| 47 |
A systematic review of the indirect costs of schizophrenia in Europe
Ahmad Nader Fasseeh, Bertalan Németh, Anett Molnár et al. · European Journal of Public Health
ReviewOpen access |
15 Oct 2018 |
47 |
| 48 |
A systematic review of health economic models and utility estimation methods in schizophrenia
Bertalan Németh, Ahmad Nader Fasseeh, Anett Molnár et al. · Expert Review of Pharmacoeconomics & Outcomes Research
Review |
19 Jan 2018 |
47 |
| 49 |
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
Antal Tamás Zemplenyi, Konstantin Tachkov, László Balkányi et al. · Frontiers in Public Health
Open access |
26 Apr 2023 |
44 |
| 50 |
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
Heleen Vellekoop, Simone A. Huygens, Matthijs Versteegh et al. · PharmacoEconomics
Open access |
16 Apr 2021 |
44 |